Bogart Wealth’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
Bogart Wealth's XBI Position: Q3 2026 in Review
Bogart Wealth held its State Street SPDR S&P Biotech ETF (XBI) position steady in Q3 2026 at 6 shares worth $952. The position accounts for ﹤0.01% of the portfolio, ranked #1649.
Bogart Wealth first reported a position in XBI in Q4 2020 and has held it in 21 quarters since. The position peaked at $130K in Q1 2021. 964 funds tracked by Wall St. Rank hold XBI as of Q3 2026.
- Bogart Wealth held 6 shares of State Street SPDR S&P Biotech ETF worth $952 as of Q3 2026.
- Bogart Wealth left its State Street SPDR S&P Biotech ETF share count unchanged in Q3 2026.
- State Street SPDR S&P Biotech ETF made up ﹤0.01% of Bogart Wealth's portfolio in Q3 2026, its #1649 holding.
- Bogart Wealth first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 21 quarters since.
- Bogart Wealth's State Street SPDR S&P Biotech ETF position peaked at $130K in Q1 2021.
- 964 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.
Based on Bogart Wealth's 13F filing for Q3 2026, filed 10 Nov 2026.